Published in Front Immunol on June 30, 2017
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS (2010) 2.83
Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics (1997) 2.09
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation (1999) 1.99
A general framework for the evaluation of clinical trial quality. Rev Recent Clin Trials (2009) 1.80
Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. J Infect Dis (2013) 1.79
Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg Med Chem (2006) 1.58
Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature (2015) 1.28
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials. Proc Natl Acad Sci U S A (2012) 1.22
Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem (2002) 1.17
Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol (1994) 1.16
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol (2010) 1.09
Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis (Edinb) (2013) 1.09
Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci (2010) 1.08
Gene expression profiling analysis of Mycobacterium tuberculosis genes in response to salicylate. Arch Microbiol (2005) 1.04
Towards host-directed therapies for tuberculosis. Nat Rev Drug Discov (2015) 1.01
Tuberculous cerebrovascular disease: a review. J Infect (2009) 0.97
The role of aspirin in childhood tuberculous meningitis. J Child Neurol (2011) 0.97
The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents (2000) 0.97
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis. J Antimicrob Chemother (2006) 0.96
Salicylate reduces susceptibility of Mycobacterium tuberculosis to multiple antituberculosis drugs. Antimicrob Agents Chemother (2002) 0.94
Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. Int J Antimicrob Agents (2007) 0.93
Involvement of protein IF2 N domain in ribosomal subunit joining revealed from architecture and function of the full-length initiation factor. Proc Natl Acad Sci U S A (2013) 0.92
Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies. Semin Immunopathol (2015) 0.91
Assessment of the Efficacy of New Anti-Tuberculosis Drugs. Open Infect Dis J (2008) 0.91
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Semin Immunopathol (2015) 0.90
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open (2013) 0.86
Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment. J Infect Dis (2013) 0.86
Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob Agents Chemother (2010) 0.86
Antibacterial activity of the anti-inflammatory compound ibuprofen. Lett Appl Microbiol (1995) 0.85
DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chem Biol (2014) 0.85
Tuberculosis. Nat Rev Dis Prim (2016) 0.85
Organotin meclofenamic complexes: Synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid - novel anti-tuberculosis agents. J Inorg Biochem (2009) 0.84
T-cell lung granulomas induced by sepharose-coupled Mycobacterium tuberculosis protein antigens: immunosuppressive phenomena reversed with cyclophosphamide and indomethacin. Immunology (1995) 0.83
Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents (2007) 0.83
Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Dis J (2007) 0.82
Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates. Clin Infect Dis (2015) 0.81
Mycobacterial escape from macrophage phagosomes to the cytoplasm represents an alternate adaptation mechanism. Sci Rep (2016) 0.80
Antibacterial activity of the antiinflammatory agent diclofenac sodium. Indian J Exp Biol (1998) 0.80
Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis. J Infect Dis (2013) 0.78
Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore. Bioorg Med Chem (2015) 0.78
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs. Br Med Bull (2016) 0.77
Role of antigen-presenting cells in variation in immunogenicity of mycobacteria. Clin Exp Immunol (1990) 0.77
Aspirin antagonism in isoniazid treatment of tuberculosis in mice. Antimicrob Agents Chemother (2006) 0.77
Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration. Tubercle (1979) 0.76
INHIBITION OF PYRAZINAMIDE HYPERURICEMIA BY SMALL DOSES OF ACETYLSALICYLIC ACID. Ann Intern Med (1964) 0.76
In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium. Indian J Exp Biol (2004) 0.76
Anti-inflammatory drugs interacting with Zn (II) metal ion based on thiocyanate and azide ligands: synthesis, spectroscopic studies, DFT calculations and antibacterial assays. Spectrochim Acta A Mol Biomol Spectrosc (2014) 0.76